DART Centre Launch

Please join us in celebrating the opening of the ARC Industrial Transformation Training Centre for the Development of Advanced Radiochemical Technologies.

Students, Centre participants, and research and professional staff are all invited. At the event we will outline the objectives of the Centre, hear from an industry speaker from the field of radiochemical therapeutics, and officially celebrate the launch of DART.

3:15p Networking

3:30p Centre Launch

4:15p Tea and networking

As the venue is a restricted space, registration is required to attend.

Invited Speaker: Simone Leyden AM

Senior Director

Global Public Affairs & Patient Advocacy –

Telix Pharmaceuticals

Simone has more than 16 years in health advocacy and public policy, having co-founded NeuroEndocrine Cancer Australia in 2009 after witnessing firsthand the huge disparity in treatment and support for rare and less common cancers. Simone’s pursuit for equitable access and investment in breakthrough treatments led to her current role at Telix Pharmaceuticals, in which she covers co-investment opportunities with governments in sovereign manufacturing, public policy that improves access for patients, and ensuring a corporate culture of patients as partners within all aspects of drug development and delivery.

Simone was recently selected as Chair of the newly formed Nuclear Medicines Australia which has a principal purpose of bringing together industry experts to provide informed advocacy to key decision makers about creating a sustainable nuclear medicines ecosystem, and to support improved patient outcomes. Simone is a graduate of the Australian Institute of Company Directors, and in 2023 was appointed a Member of the Order of Australia (AM) as part of the Kings Birthday Honours, for significant service to community health, particularly through neuroendocrine cancer organisations.